Previously treated cases tested for RR-/MDR-TB in Upper-middle income (World Bank)

Upper-middle income (World Bank): Previously treated cases tested for RR-/MDR-TB was 83.0% in 2024. ◆ Volatile

Latest (2024)
83.0%
Change on year
down 5.7%
Rank
5th
of 11 groups
All-time high
92.0%
in 2018
All-time low
5.4%
in 2005
Years of data
20
2005–2024

Previously treated cases tested for RR-/MDR-TB in Upper-middle income (World Bank), 2005–2024

0204060801002005201420242005: 5.42006: 6.22007: 6.42008: 5.72009: 9.72010: 112011: 122012: 212013: 322014: 482015: 622016: 592017: 852018: 922019: 762020: 892021: 892022: 792023: 882024: 83

Source: World Health Organization, Global Health Observatory.

Analysis

Upper-middle income (World Bank) recorded 83.0% for previously treated cases tested for rr-/mdr-tb in 2024.

That represents a change of down 5.7% on the previous year and up 72.9% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Upper-middle income (World Bank) peaked at 92.0% in 2018 and was at its lowest, 5.4%, in 2005.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in Upper-middle income (World Bank), year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Upper-middle income (World Bank), 2005 to 2024.
Year Value Change
2005 5.4%
2006 6.2% +14.8%
2007 6.4% +3.2%
2008 5.7% -10.9%
2009 9.7% +70.2%
2010 11.0% +13.4%
2011 12.0% +9.1%
2012 21.0% +75.0%
2013 32.0% +52.4%
2014 48.0% +50.0%
2015 62.0% +29.2%
2016 59.0% -4.8%
2017 85.0% +44.1%
2018 92.0% +8.2%
2019 76.0% -17.4%
2020 89.0% +17.1%
2021 89.0% +0.0%
2022 79.0% -11.2%
2023 88.0% +11.4%
2024 83.0% -5.7%

Averages by decade

DecadeAverage LowestHighest Years
2000s 6.7% 5.4% 9.7% 5
2010s 49.8% 11.0% 92.0% 10
2020s 85.6% 79.0% 89.0% 5

More health data for Upper-middle income (World Bank)

All data for Upper-middle income (World Bank) →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Upper-middle income (World Bank)?
Previously treated cases tested for rr-/mdr-tb in Upper-middle income (World Bank) was 83.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Upper-middle income (World Bank)?
The highest recorded value was 92.0% in 2018.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Upper-middle income (World Bank)?
The lowest recorded value was 5.4% in 2005.
How does Upper-middle income (World Bank) rank for previously treated cases tested for rr-/mdr-tb?
Upper-middle income (World Bank) ranks 5th out of 11 groups with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Upper-middle income (World Bank)?
Over the last ten years it is up 72.9%. The long-run trend across the full record is volatile.
Where does this Upper-middle income (World Bank) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Upper-middle income (World Bank). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 07 September 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/upper-middle-income-world-bank/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/upper-middle-income-world-bank/">Previously treated cases tested for RR-/MDR-TB in Upper-middle income (World Bank)</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed